This meeting took place in 2014


Here are the related meetings in 2020:
Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches (Q6)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Fibrosis: From Bench to Bedside (C4)


Organizer(s) Jeremy S. Duffield, Steven R. Ledbetter and John P. Iredale
March 23—28, 2014
Keystone Resort • Keystone, Colorado USA
Discounted Abstract Deadline: Nov 20, 2013
Abstract Deadline: Dec 18, 2013
Scholarship Deadline: Nov 20, 2013
Discounted Registration Deadline: Jan 21, 2014

Sponsored by Gilead Sciences, Inc., InterMune, Inc., MedImmune, Shire Human Genetic Therapies and Takeda Pharmaceutical Company Limited

Summary of Meeting:
Fibrosis of all the internal organs is increasingly recognized as a deleterious and ominous consequence of, normal aging, repetitive subclinical tissue injury or severe persistent tissue injury. Fibrosis is increasingly seen as the next broad-ranging target for therapeutics after Cancer, and there is now a rush to first-in-class therapeutics. The primary cell that lays down fibrotic tissue is the myofibroblast. Until very recently, the biology of myofibroblasts is relatively undeveloped due to a lack of definitive markers, and lack of clear ontogeny. This meeting: 1) Brings together biotech, pharma and academia in a seamless meeting. 2) Focuses on fibrosis as an abnormal wound healing or tissue repair response identifying aberrant developmental pathways, and progenitor cell responses. c) Has a broad focus on basic biology of myofibroblasts, their progenitors, progenitor ontogeny, and their interaction with the immune system in disease. d) Focuses on fibrosis as a normal part of aging and the epigenetics involved in maintaining myofibroblasts in an activated state. e) Includes a full session on biomarkers; among the major blocks to progress is the lack of biomarkers. f) Feature formal presentations from biotech/pharma on the most promising new therapeutics in development or clinical trial. All of these highlighted areas are underdeveloped and are rapidly changing. The Keystone Symposia Fibrosis meeting is intended to be the premier international meeting for anyone with an interest in this disease process. The meeting brings together academics from a broad range of interest areas, including cancer, vascular biology, stem cell biology and tissue regeneration, as well as those with organ specific-interests.

View Meeting Program

Scholarships/Awards

Biogen Scholarship Recipients

Rudel Anton Saunders
University of Michigan, USA

Biogen Idec ECITA Scholarship Recipients

Steven A. Saenz
Celgene Corp, USA

Keystone Symposia Future of Science Fund Scholarship Recipients

Franco Klingberg
University of Toronto, Canada

Pei Xiong Liew
Snyder Institute of Chronic Diseases, Canada

Agata Page
Newcastle University, UK

Tien Peng
University of Pennsylvania, USA

David Zhang
Mount Sinai School of Medicine, USA

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Cristi L. Galindo
Vanderbilt University, USA

The Barrie Hesp Scholarship on behalf of Ashley Rebecca Cukier Scholarship Recipients

David Lagares
Massachusetts General Hospital, USA